A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia
NCT04205214 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2020-09-22
Summary
This Randomised Control Trial (RCT) aims to test a novel Alopecia-tailored, protocolled, integrative individual psychological intervention offered to patients with enduring Alopecia. The pilot study aims to assess the impact of the intervention on 8 patients, by assessing changes in their psychological and physical symptoms (stress, anxiety, depression, quality of life, scalp hair, and other bio-markers) compared to 7 patients in the wait-list control group.
Conditions
Interventions
- BEHAVIORAL
-
Integrative Cognitive Behavioural Therapy
This intervention involves the psychological intervention of Cognitive Behavioural Therapy. This intervention also includes third wave psychological interventions of Mindfulness and Narrative Therapy which has been found to be helpful for people with chronic health conditions and chronic skin conditions.
Sponsors & Collaborators
-
Royal Free Hospital NHS Foundation Trust
collaborator OTHER -
City, University of London
lead OTHER
Principal Investigators
-
Sharon Hart, Doctorate · Royal Free Hospital NHS Foundation Trust
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2020-02-02
- Completion
- 2020-02-13
Countries
- United Kingdom
Study Locations
More Related Trials
-
Assessment of the Effects and Tolerance of the RV4986A Lotion in Men With AGA After Hair Transplant
NCT06576492 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
NCT03941548 ·Status: COMPLETED ·Phase: PHASE2
-
Stepped Care in the Treatment of Trichotillomania
NCT01118637 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Low-Dose Oral Minoxidil as Treatment of Permanent Chemotherapy-Induced Alopecia
NCT03831334 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Computer-Assisted Versus Manual Hair Harvest Comparative Study
NCT00926211 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females
NCT03052413 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
NCT06762548 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Follicular Revival in Androgenic Alopecia: Evaluating Use of Micro-needling
NCT04341363 ·Status: COMPLETED ·Phase: NA
-
Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation
NCT06145672 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata
NCT03137381 ·Status: COMPLETED ·Phase: PHASE2
-
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata
NCT04239521 ·Status: COMPLETED
-
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
NCT06501924 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Psychosocial Stress on QOL in Saudi Arabian Patients with Alopecia Areata
NCT06802705 ·Status: COMPLETED
-
Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium
NCT06545552 ·Status: COMPLETED ·Phase: NA
-
The Efficiency Of The Methotrexate At Patients Affected By Grave Pelade
NCT02037191 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
NCT06826196 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Abatacept Costimulatory Blockade in the Treatment of Alopecia Totalis/Universalis
NCT01314495 ·Status: WITHDRAWN ·Phase: PHASE2
-
Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia
NCT06854432 ·Status: TERMINATED ·Phase: NA
-
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
NCT02974868 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata
NCT07029711 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
NCT03811912 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy and Safety of Oral Roflumilast Versus Intralesional Corticosteroids Injection (ILCs) in the Treatment of Alopecia Areata
NCT07174011 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
NCT00408798 ·Status: COMPLETED ·Phase: NA
-
To Investigate Efficacy of FOL-005 on Hair Growth on Scalp Skin
NCT03467412 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Tofacitinib for the Treatment of Alopecia Areata and Its Variants
NCT02812342 ·Status: COMPLETED ·Phase: PHASE2